Patent medicine name
Epclusa 28s
Manufacturer
Gilead Sciences Ltd
Specification
Physical Form: Tablets, Quantity: 28pill/bottle, Storage: Room Temperature(10-30°C)
Price
$26000- 26050
Generic medicine name & Manufacturer
Resof Total 400mg/100mg 28 Tablet
Specification
Physical Form: Tablet, Quantity: 28/bottle, Storage: Room Temperature(10-30°C)
Price
$260-270
Composition
Sofosbuvir 400mg + Velpatasvir 100mg
Use
The fixed-dose combination sofosbuvir-velpatasvir (400 mg/100 mg) is FDA-approved for the treatment of chronic hepatitis C genotypes 1 to 6 for the following patient populations: Patients without cirrhosis and patients with compensated cirrhosis (Child-Pugh A)
Medicince introduction including background, function, caution, etc.
Indication
It is used in the treatment of chronic hepatitis C virus (HCV) infection.
Side effects
Headache, Tiredness.
Mechanisam of Action
It is a combination of two antiviral medicines: Sofosbuvir 400mg and Velpatasvir 100mg. They work by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time.
Use in Other language
Picture